T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBG
726
DELISTED
Bill Barrett Corp
BBG
| $73.6M | 0.02% |
2,747,832
-620,140
| -18% | -$15.8M |
|
|
LPNT
727
DELISTED
LifePoint Health, Inc.
LPNT
| $73.3M | 0.02% |
1,180,727
+207,410
| +21% | +$12.2M |
|
728
AZZ Inc
AZZ
$4.52B
| $72.8M | 0.02% |
1,579,966
-45,208
| -3% | -$1.99M |
|
729
PACCAR
PCAR
$68.8B
| $72.8M | 0.02% |
1,737,747
+403,570
| +30% | +$17.2M |
|
730
Aramark
ARMK
$16.1B
| $72.7M | 0.02% |
3,893,235
-529,015
| -12% | -$10.3M |
|
731
NextEra Energy
NEE
$179B
| $72.7M | 0.02% |
2,837,896
+31,428
| +1% | +$765K |
|
|
ASEI
732
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $72.5M | 0.02% |
1,042,253
+10,900
| +1% | +$731K |
|
733
Check Point Software Technologies
CHKP
$13.7B
| $72.4M | 0.02% |
1,079,500
-22,700
| -2% | -$1.49M |
|
734
Matthews International
MATW
$722M
| $72.2M | 0.02% |
1,736,340
+532,950
| +44% | +$21.8M |
|
735
Jazz Pharmaceuticals
JAZZ
$16B
| $72.1M | 0.02% |
490,200
-439,150
| -47% | -$60.9M |
|
736
United Therapeutics
UTHR
$21.5B
| $72M | 0.02% |
813,852
+8,295
| +1% | +$798K |
|
737
Eldorado Gold
EGO
$10B
| $71.8M | 0.02% |
1,875,406
-701,984
| -27% | -$21.5M |
|
738
Prosperity Bancshares
PB
$8.97B
| $71.8M | 0.02% |
1,146,860
-13,880
| -1% | -$840K |
|
739
Eagle Materials
EXP
$6.41B
| $71.6M | 0.02% |
759,733
+386,535
| +104% | +$33.8M |
|
740
CMS Energy
CMS
$22.1B
| $71.5M | 0.02% |
2,294,634
-55,137
| -2% | -$1.64M |
|
|
PNRA
741
DELISTED
Panera Bread Co
PNRA
| $71.4M | 0.02% |
476,424
-1,197,450
| -72% | -$190M |
|
742
Winnebago Industries
WGO
$921M
| $71.4M | 0.02% |
2,834,210
+18,900
| +0.7% | +$464K |
|
743
Sempra
SRE
$56.5B
| $71.3M | 0.02% |
1,362,640
+8,850
| +0.7% | +$439K |
|
|
TNGO
744
DELISTED
Tangoe, Inc.
TNGO
| $71.2M | 0.02% |
4,728,910
+483,490
| +11% | +$7.49M |
|
|
CSOD
745
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $70.9M | 0.02% |
1,540,917
+844,892
| +121% | +$34.4M |
|
746
Williams Companies
WMB
$89.3B
| $70.5M | 0.02% |
1,211,233
-198,135
| -14% | -$9.18M |
|
747
UFP Industries
UFPI
$5.03B
| $70.3M | 0.02% |
4,366,050
-9,900
| -0.2% | -$167K |
|
|
FPO
748
DELISTED
First Potomac Realty Trust
FPO
| $70.2M | 0.02% |
5,350,147
+145,239
| +3% | +$1.89M |
|
|
CRAY
749
DELISTED
Cray, Inc.
CRAY
| $70.1M | 0.02% |
2,633,867
+167,590
| +7% | +$4.84M |
|
|
SIAL
750
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $69.8M | 0.02% |
688,112
-42,472
| -6% | -$4.12M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.